EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.1.4.35 | additional information | phosphorylation acts in concert with allosteric cGMP binding to stimulate the PDE5 catalytic site, which should promote negative feedback regulation of the cGMP pathway in intact cells | Homo sapiens | |
3.1.4.35 | additional information | phosphorylation acts in concert with allosteric cGMP binding to stimulate the PDE5 catalytic site, which should promote negative feedback regulation of the cGMP pathway in intact cells | Bos taurus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.1.4.35 | - |
Homo sapiens |
3.1.4.35 | - |
Bos taurus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.1.4.35 | tadalafil | cGMP modestly but significantly increases the affinity of PDE5 for tadalafil by 1.7fold | Bos taurus | |
3.1.4.35 | tadalafil | cGMP modestly but significantly increases the affinity of PDE5 for tadalafil by 1.7fold | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.1.4.35 | 0.0247 | - |
2'-O-anthraniloyl-cGMP | phosphorylated PDE5, at 30°C with 50 mM Tris-HCl, pH 7.5 | Homo sapiens | |
3.1.4.35 | 0.0651 | - |
2'-O-anthraniloyl-cGMP | unphosphorylated PDE5, at 30°C with 50 mM Tris-HCl, pH 7.5 | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.4.35 | Bos taurus | - |
- |
- |
3.1.4.35 | Homo sapiens | - |
- |
- |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
3.1.4.35 | side-chain modification | PDE5 is phosphorylated at Ser102 by cyclic nucleotide-dependent protein kinases, phosphorylation activates PDE5 catalytic site independently of cGMP binding to the allosteric sites | Homo sapiens |
3.1.4.35 | side-chain modification | PDE5 is phosphorylated at Ser92 by cyclic nucleotide-dependent protein kinases, phosphorylation activates PDE5 catalytic site independently of cGMP binding to the allosteric sites | Bos taurus |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.1.4.35 | Ni-NTA agarose column chromatography | Homo sapiens |
3.1.4.35 | Ni-NTA agarose column chromatography | Bos taurus |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.4.35 | 2'-O-anthraniloyl-cGMP + H2O | phosphorylation increases affinity for hydrolysis of 2'-O-anthraniloyl-cGMP by about 3fold | Homo sapiens | ? | - |
? | |
3.1.4.35 | 2'-O-anthraniloyl-cGMP + H2O | phosphorylation increases affinity for hydrolysis of 2'-O-anthraniloyl-cGMP by about 3fold | Bos taurus | ? | - |
? | |
3.1.4.35 | 3',5'-cGMP + H2O | - |
Homo sapiens | 5'-GMP | - |
? | |
3.1.4.35 | 3',5'-cGMP + H2O | - |
Bos taurus | 5'-GMP | - |
? | |
3.1.4.35 | additional information | tadalafil is not degraded by PDE5 | Homo sapiens | ? | - |
? | |
3.1.4.35 | additional information | tadalafil is not degraded by PDE5 | Bos taurus | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.4.35 | PDE5 | - |
Homo sapiens |
3.1.4.35 | PDE5 | - |
Bos taurus |
3.1.4.35 | phosphodiesterase-5 | - |
Homo sapiens |
3.1.4.35 | phosphodiesterase-5 | - |
Bos taurus |